These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3036758)

  • 1. Concentration-dependent interaction of theophylline with d-tubocurarine.
    Fuke N; Martyn J; Kim CS; Basta S
    J Appl Physiol (1985); 1987 May; 62(5):1970-4. PubMed ID: 3036758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine.
    Hogue CW; Ward JM; Itani MS; Martyn JA
    J Appl Physiol (1985); 1992 Apr; 72(4):1326-31. PubMed ID: 1592722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Anesth Analg; 1990 Jul; 71(1):55-9. PubMed ID: 2363529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine: effects on neuromuscular transmission.
    Dretchen KL; Morgenroth VH; Standaert FG; Walts LF
    Anesthesiology; 1976 Dec; 45(6):604-9. PubMed ID: 185925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat.
    Ibebunjo C; Donati F; Fox GS; Eshelby D; Tchervenkov JI
    Anesth Analg; 1997 Aug; 85(2):431-6. PubMed ID: 9249126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in man with a constant-rate infusion of tubocurarine.
    Shanks CA; Ramzan MI; Triggs EJ
    Anaesth Intensive Care; 1979 Aug; 7(3):209-14. PubMed ID: 495928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine fails to alter the dose-response curve of d-tubocurarine in rats.
    Glidden RS; Martyn JA; Tomera JF
    Anesthesiology; 1988 Apr; 68(4):595-8. PubMed ID: 3354895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat.
    Ham J; Miller RD; Benet LZ; Matteo RS; Roderick LL
    Anesthesiology; 1978 Nov; 49(5):324-9. PubMed ID: 736287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction.
    Hogue CW; Itani MS; Martyn JA
    Anesthesiology; 1990 Oct; 73(4):703-9. PubMed ID: 2221439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal endotoxin but not protein malnutrition shifts d-tubocurarine dose-response curves in mouse gastrocnemius muscle.
    Tomera JF; Martyn J
    J Pharmacol Exp Ther; 1989 Jul; 250(1):216-20. PubMed ID: 2545858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of lipopolysaccharide endotoxin produced from Escherichia coli with D-tubocurarine at the nicotinic2 receptor and adenosine 3':5' cyclic monophosphate during physiological contraction in skeletal muscle.
    Tomera JF
    Food Chem Toxicol; 1996 Jan; 34(1):63-72. PubMed ID: 8603799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A microelectrode study of the antagonism of d-tubocurarine induced neuromuscular blockade by edrophonium and neostigmine].
    Narimatsu E
    Masui; 1993 Jan; 42(1):25-36. PubMed ID: 8433489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium nitroprusside on the biophase concentration of D-tubocurarine at the neuromuscular junction.
    Chang P; Geh SL
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):433-6. PubMed ID: 3742886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tubocurarine administered by combined i.v. bolus and infusion.
    Ramzan MI; Shanks CA; Triggs EJ
    Br J Anaesth; 1980 Sep; 52(9):893-9. PubMed ID: 7437228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of tubocurarine in humans.
    Wingard LB; Cook DR
    Br J Anaesth; 1976 Sep; 48(9):839-45. PubMed ID: 183799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium and neuromuscular transmission.
    Waud BE; Farrell L; Waud DR
    Anesth Analg; 1982 May; 61(5):399-402. PubMed ID: 6278988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of muscle relaxation with a combination of pancuronium and tubocurarine.
    Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM
    Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bretylium on neuromuscular transmission.
    Welch GW; Waud BE
    Anesth Analg; 1982 May; 61(5):442-4. PubMed ID: 6278989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the dissociation constant of d-tubocurarine and the receptor for endogenous acetylcholine.
    Bowen JM
    J Pharmacol Exp Ther; 1972 Nov; 183(2):333-40. PubMed ID: 4343415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.